StockData
Veracyte, Inc. logo

Veracyte, Inc. (VCYT) stock

VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3029% below fair value
$25.13+0.09 (+0.36%)

Close on Nov 20, 2026Market cap $2.02BP/E 17.9Yield –

Veracyte shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Veracyte's shares outstanding was 82M at Jun 30, 2026. For fiscal 2025 it was 81M, up 3.1% from the year before. Over ten years it grew 12.0% a year on average. The highest annual figure on record is 81M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202581M+3.1%
FY2024Dec 31, 202478M+7.6%
FY2023Dec 31, 202373M+1.5%
FY2022Dec 31, 202272M+5.4%
FY2021Dec 31, 202168M+27.5%
FY2020Dec 31, 202053M+15.4%
FY2019Dec 31, 201946M+24.6%
FY2018Dec 31, 201837M+9.1%
FY2017Dec 31, 201734M+17.7%
FY2016Dec 31, 201629M+10.9%
FY2015Dec 31, 201526M+20.1%
FY2014Dec 31, 201422M+420.3%
FY2013Dec 31, 20134M+539.5%
FY2012Dec 31, 20121M+12.1%
FY2011Dec 31, 20111M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202682M+4.7%
Q1 FY2026Mar 31, 202681M+1.6%
Q4 FY2025Dec 31, 202582M+2.3%
Q3 FY2025Sep 30, 202580M+1.6%
Q2 FY2025Jun 30, 202578M+1.6%
Q1 FY2025Mar 31, 202580M+7.1%
Q4 FY2024Dec 31, 202481M+10.3%
Q3 FY2024Sep 30, 202478M+7.8%
Q2 FY2024Jun 30, 202477M+6.5%
Q1 FY2024Mar 31, 202475M+3.6%
Q4 FY2023Dec 31, 202373M+1.8%
Q3 FY2023Sep 30, 202373M+1.6%
Q2 FY2023Jun 30, 202372M+1.4%
Q1 FY2023Mar 31, 202372M+1.3%
Q4 FY2022Dec 31, 202272M+1.0%
Q3 FY2022Sep 30, 202272M+2.7%
Q2 FY2022Jun 30, 202271M+6.2%
Q1 FY2022Mar 31, 202271M+12.5%
Q4 FY2021Dec 31, 202171M+22.5%
Q3 FY2021Sep 30, 202170M+27.1%
Q2 FY2021Jun 30, 202167M+34.1%
Q1 FY2021Mar 31, 202163M+27.2%
Q4 FY2020Dec 31, 202058M+18.2%
Q3 FY2020Sep 30, 202055M+12.9%
Q2 FY2020Jun 30, 202050M+10.1%
Q1 FY2020Mar 31, 202050M+20.9%
Q4 FY2019Dec 31, 201949M+20.5%
Q3 FY2019Sep 30, 201949M+25.8%
Q2 FY2019Jun 30, 201946M+32.8%
Q1 FY2019Mar 31, 201941M+20.1%
Q4 FY2018Dec 31, 201841M+16.2%
Q3 FY2018Sep 30, 201839M+13.8%
Q2 FY2018Jun 30, 201834M+1.3%
Q1 FY2018Mar 31, 201834M+1.3%
Q4 FY2017Dec 31, 201735M+10.6%
Q3 FY2017Sep 30, 201734M+21.6%
Q2 FY2017Jun 30, 201734M–
Q1 FY2017Mar 31, 201734M–
Q4 FY2016Dec 31, 201632M–
Q3 FY2016Sep 30, 201628M–

More Veracyte figures

See a number that looks wrong?